SMTL ID : 3gnw.2 (1 other biounit)

HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 4c

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.39 Å

Oligo State

monomer

Ligands

1 x XNC: (11S)-11-[4-(benzyloxy)-2-fluorophenyl]-3,3-dimethyl-10-[(6-methylpyridin-2-yl)carbonyl]-2,3,4,5,10,11-hexahydrothiopyrano[3,2-b][1,5]benzodiazepin-6-ol 1,1-dioxide(Non-covalent)

XNC.1: 19 residues within 4Å: Chain A: R.161, F.196, P.200, R.203, S.368, C.369, S.370, S.371, L.387, R.389, S.410, N.414, M.417, Y.418, Q.449, I.450, Y.451, G.452, S.559 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:P.200, A:L.387, A:L.387, A:Y.418 Hydrogen bonds: A:S.370, A:R.389, A:S.559 Water bridges: A:N.319, A:C.369, A:R.389, A:Y.558

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 2 residues within 4Å: Chain A: R.397, N.414 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vandyck, K. et al., Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase. J.Med.Chem. (2009)

Release Date

2009-10-20

Peptides

RNA-directed RNA polymerase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

RNA-directed RNA polymerase

Related Entries With Identical Sequence